Profile
Stephanie Noviello worked as Vice President-Clinical Development at Motif Bio Plc from 2018 to 2019.
She completed her undergraduate degree at Cornell University, her doctorate at Tulane University School of Medicine, and her graduate degree at Tulane University School of Public Health & Tropical Medicine.
Former positions of Stephanie Noviello
| Companies | Position | End |
|---|---|---|
| MOTIF BIO PLC | Corporate Officer/Principal | 2019-04-30 |
Training of Stephanie Noviello
| Tulane University School of Medicine | Doctorate Degree |
| Tulane University School of Public Health & Tropical Medicine | Graduate Degree |
| Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Stephanie Noviello
